ROTHBLATT MARTINE A — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

ROTHBLATT MARTINE A has filed 58 SEC Form 4 filings across 2 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $864K. Lifetime open-market sales: $489.82M.

Profile

ROTHBLATT MARTINE A

Martine A. Rothblatt is an American biotech entrepreneur, attorney, author, and advocate. She is best known as the founder of United Therapeutics Corporation, a public biotechnology company focused on treatments for pulmonary arterial hypertension and other diseases. Rothblatt is also recognized for co-founding Sirius Satellite Radio (which evolved into Sirius XM Holdings) and for her public advocacy on transgender rights. In addition to her business ventures, she has been involved in the Terasem movement, which explores life extension, digital immortality, and related technologies. Rothblatt has authored books and contributed to discussions at the intersection of science, law, and social policy.

RoleInsider
Notability90/100
LinksWikipedia

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-15UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]200$532.60$107K
2026-07-15UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]107$531.08$57K
2026-07-15UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]554$530.67$294K
2026-07-15UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]959$529.21$508K
2026-07-15UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]660$528.13$349K
2026-07-15UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]1.2K$527.06$643K
2026-07-15UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]3.5K$526.13$1.84M
2026-07-15UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]1.5K$525.16$771K
2026-07-15UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]840$524.15$440K
2026-07-15UTHRUNITED THERAPEUTICS CorpM — Option exercise [10b5-1]9.5K$135.42$1.29M
2026-07-14UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]40$542.80$22K
2026-07-14UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]360$541.10$195K
2026-07-14UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]320$539.60$173K
2026-07-14UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]409$538.60$220K
2026-07-14UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]665$537.66$358K
2026-07-14UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]2.2K$536.52$1.19M
2026-07-14UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]2.2K$535.47$1.17M
2026-07-14UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]2.3K$534.63$1.21M
2026-07-14UTHRUNITED THERAPEUTICS CorpS — Open-market sale [10b5-1]1.0K$533.70$544K
2026-07-14UTHRUNITED THERAPEUTICS CorpM — Option exercise [10b5-1]9.5K$135.42$1.29M

Companies — Last 90 Days

Frequently Asked Questions

Who is ROTHBLATT MARTINE A?

Martine A. Rothblatt is an American biotech entrepreneur, attorney, author, and advocate. She is best known as the founder of United Therapeutics Corporation, a public biotechnology company focused on treatments for pulmonary arterial hypertension and other diseases. Rothblatt is also recognized for co-founding Sirius Satellite Radio (which evolved into Sirius XM Holdings) and …

How many SEC Form 4 filings has ROTHBLATT MARTINE A submitted recently?

58 primary Form 4 filings in the last 90 days, covering 2 companies.

Has ROTHBLATT MARTINE A been buying or selling stock?

Recorded transactions: 1 open-market purchases ($864K) and 997 open-market sales ($489.82M) across all tracked filings.

Where can I see all of ROTHBLATT MARTINE A's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live ROTHBLATT MARTINE A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.